Gregory A. Masters

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Christopher G. Azzoli, Sherman Baker, Sarah Temin et al. · Journal of Clinical Oncology · 2009 · 913 citations · Full text

Medicine, Oncology, Pharmacology +17

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Gregory A. Masters, Sarah Temin, Christopher G. Azzoli et al. · Journal of Clinical Oncology · 2015 · 851 citations

Medicine, Oncology, Chemotherapy +12

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

Julie R. Brahmer, Hamzah Abu‐Sbeih, Paolo A. Ascierto et al. · Journal for ImmunoTherapy of Cancer · 2021 · 826 citations · Full text

Pharmacy, Immunology, Oncology +17

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients

Thomas Condamine, George A. Dominguez, Je‐In Youn et al. · Science Immunology · 2016 · 799 citations

Medicine, Immunology, Oncology +17